This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

William Barry, MD; Luanne Hudgins, MD; Sam T. Donta, MD; Edward L. Pesanti, MD

JAMA. 1992;267(24):3315-3316.

Abstract
Staphylococcus aureus and group A Streptococcus pyogenes produce toxic shock syndrome characterized by hypotension and multisystem organ failure. While conventional therapy has consisted of antibiotics and intensive supportive care, some experimental evidence suggests that immunoglobulins directed against the toxins may be effective additional therapy. We report a case of "toxic strep syndrome" in which intravenous immunoglobulin was administered when signs and symptoms were worsening while the patient was receiving conventional therapy. Within hours of administration of the intravenous immunoglobulin, the patient experienced dramatic clinical improvement. This response suggests a possible therapeutic benefit of intravenous immunoglobulin in toxic shock syndrome.

(JAMA. 1992;267:3315-3316)

Author Affiliations
From the University of Connecticut Health Center, Farmington (Drs Barry, Hudgins, Donta, and Pesanti) and the Department of Veterans Affairs Medical Center, Newington, Conn (Drs Donta and Pesanti). Dr Hudgins is now with the University of Arizona College of Medicine, Phoenix.

Footnotes
Reprint requests to Medical Service, Veterans Affairs Medical Center, 555 Willard Ave, Newington, CT 06111 (Dr Pesanti).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Therapeutic Considerations for Children With Invasive Group A Streptococcal Infections: A Case Series Report and Review of the Literature
Burnett and Domachowske
CLIN PEDIATR 2007;46:550-555.
 

Necrotizing Fasciitis Caused by Group A Streptococcus: Case Report and Therapy Update
Larose-Pierre et al.
Journal of Pharmacy Practice 2002;15:290-296.
ABSTRACT  

Group A Streptococcal bacteraemia and necrotizing faciitis in a renal transplant patient: a case for intravenous immunoglobulin therapy
Korzets et al.
Nephrol Dial Transplant 2002;17:150-152.
FULL TEXT  

Passive Immunity in Prevention and Treatment of Infectious Diseases
Keller and Stiehm
Clin. Microbiol. Rev. 2000;13:602-614.
ABSTRACT | FULL TEXT  

Primary Peritonitis Associated with Streptococcal Toxic Shock-like Syndrome
Watson and Powers
CLIN PEDIATR 1999;38:175-177.
 

Case 36-1998- An 11-Year-Old Girl with Fever, Hypotension, and Azotemia
Rhodes et al.
NEJM 1998;339:1619-1626.
FULL TEXT  

Opsonic Antibodies to the Surface M Protein of Group A Streptococci in Pooled Normal Immunoglobulins (IVIG): Potential Impact on the Clinical Efficacy of IVIG Therapy for Severe Invasive Group A Streptococcal Infections
Basma et al.
Infect. Immun. 1998;66:2279-2283.
ABSTRACT | FULL TEXT  

Toxic Shock Syndrome in Association with Group-A Streptococcal Infection of a Knee Joint after a Total Knee Arthroplasty. A Case Report
RALPH and BOURNE
JBJS 1998;80:96-8.
FULL TEXT  

Severe Invasive Group A Streptococcal Infections: A Subject Review
Committee on Infectious Diseases
Pediatrics 1998;101:136-140.
ABSTRACT | FULL TEXT  

Streptococcal Infections of Skin and Soft Tissues
Bisno and Stevens
NEJM 1996;334:240-246.
FULL TEXT  

Group A Streptococcal Infections: An Old Adversary Reemerging With New Tricks?
Feingold and Weinberg
Arch Dermatol 1996;132:67-70.
ABSTRACT  

Treatment of Stevens-Johnson Syndrome With Pooled Human Intravenous Immune Globulin
Moudgil et al.
CLIN PEDIATR 1995;34:48-51.